The reason for this phenomenon seems to be that the previously reported anti-allergic effect such as inhibiting IL-4 and CD4+ of SCRT and its ingredients (Ikeda et al., 2002) affected the progression and remission of atopic dermatitis. The gene discussed is IL4; the disease is atopic eczema.